Chugai's Alecensa® Met Its Primary Endpoint in the ALEX Study

Go back to Chugai's Alecensa® Met Its Primary Endpoint in the ALEX Study
Chugai Pharmaceutical Ltd Unsponsored ADR (AMEX: CHGCY) Delayed: 21.47 +0.02 (0.09%)
Previous Close $21.45    52 Week High $74.63 
Open $21.58    52 Week Low $56.80 
Day High $21.67    P/E N/A 
Day Low $21.27    EPS $0.00 
Volume 182,086       

Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 55.53 +0.92 (1.68%)
Previous Close $54.61    52 Week High $35.13 
Open $55.30    52 Week Low $28.10 
Day High $55.73    P/E N/A 
Day Low $55.21    EPS $0.00 
Volume 4,588,108       

Brown & Brown, Inc. (NYSE: RO) Delayed: 8.49 +0.55 (6.93%)
Previous Close $7.94    52 Week High $8.59 
Open $7.94    52 Week Low $7.82 
Day High $8.59    P/E 6.53 
Day Low $7.82    EPS $1.30 
Volume 42,732